{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:55:17Z","timestamp":1791093317740,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1124\/mol.106.032920","type":"journal-article","created":{"date-parts":[[2007,5,9]],"date-time":"2007-05-09T02:36:24Z","timestamp":1178678184000},"page":"395-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"title":["Caffeine Inhibits Adenosine-Induced Accumulation of Hypoxia-Inducible Factor-1\u03b1, Vascular Endothelial Growth Factor, and Interleukin-8 Expression in Hypoxic Human Colon Cancer Cells"],"prefix":"10.1016","volume":"72","author":[{"given":"Stefania","family":"Merighi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Benini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prisco","family":"Mirandola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Gessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Varani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Simioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Maclennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Giovanni","family":"Baraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Andrea","family":"Borea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.106.032920_REF1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/jn\/136.1.166","article-title":"Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer","volume":"136","author":"Baker","year":"2006","journal-title":"J Nutr"},{"key":"10.1124\/mol.106.032920_REF2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/jm0109614","article-title":"Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A3 adenosine receptor antagonists","volume":"45","author":"Baraldi","year":"2002","journal-title":"J Med Chem"},{"key":"10.1124\/mol.106.032920_REF3","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0022-3565(25)20409-8","article-title":"Caffeine and theophylline as adenosine receptor antagonists in humans","volume":"258","author":"Biaggioni","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.106.032920_REF4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","article-title":"Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis","volume":"394","author":"Carmeliet","year":"1998","journal-title":"Nature"},{"key":"10.1124\/mol.106.032920_REF5","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.186.8.1201","article-title":"Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis","volume":"186","author":"Desbaillets","year":"1997","journal-title":"J Exp Med"},{"key":"10.1124\/mol.106.032920_REF6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/gut.44.5.597","article-title":"Review: substantial coffee consumption was associated with a lower risk of colorectal cancer in the general population","volume":"44","author":"Ekbom","year":"1999","journal-title":"Gut"},{"key":"10.1124\/mol.106.032920_REF7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.RES.0000012203.21416.14","article-title":"Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation","volume":"90","author":"Feoktistov","year":"2002","journal-title":"Circ Res"},{"key":"10.1124\/mol.106.032920_REF8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.RES.0000061572.10929.2D","article-title":"Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors","volume":"92","author":"Feoktistov","year":"2003","journal-title":"Circ Res"},{"key":"10.1124\/mol.106.032920_REF9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.HYP.0000144800.21037.a5","article-title":"Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype","volume":"44","author":"Feoktistov","year":"2004","journal-title":"Hypertension"},{"key":"10.1124\/mol.106.032920_REF10","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.106.032920_REF11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","article-title":"Actions of caffeine in the brain with special reference to factors that contribute to its wide-spread use","volume":"51","author":"Fredholm","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.106.032920_REF12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.106.032920_REF13","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-1134-03","article-title":"Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells","volume":"10","author":"Gessi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.106.032920_REF14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/jcp.20994","article-title":"Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine subtype","volume":"211","author":"Gessi","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1124\/mol.106.032920_REF15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0026-895X(24)12875-1","article-title":"A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study","volume":"61","author":"Gessi","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.032920_REF16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/sj.bjp.0704254","article-title":"Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells","volume":"134","author":"Gessi","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.106.032920_REF17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrd1199","article-title":"HIF-1 as a target for drug development","volume":"2","author":"Giaccia","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.106.032920_REF18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"Hockel","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/mol.106.032920_REF19","first-page":"1138","article-title":"Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1","volume":"63","author":"Krishnamachary","year":"2003","journal-title":"Cancer Res"},{"key":"10.1124\/mol.106.032920_REF20","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/82146","article-title":"Suppression of tumor growth through disruption of hypoxia-inducible transcription","volume":"6","author":"Kung","year":"2000","journal-title":"Nat Med"},{"key":"10.1124\/mol.106.032920_REF21","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/S0002-9440(10)61170-4","article-title":"Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A2A receptor agonists and endotoxin","volume":"160","author":"Leibovich","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1124\/mol.106.032920_REF22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00008390-199804000-00005","article-title":"Inhibition of melanoma pulmonary metastasis by methylxanthines due to decreased invasion and proliferation","volume":"8","author":"Lentini","year":"1998","journal-title":"Melanoma Res"},{"key":"10.1124\/mol.106.032920_REF23","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1158\/1078-0432.CCR-03-0651","article-title":"The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition","volume":"10","author":"Madi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.106.032920_REF24","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.94.15.8104","article-title":"Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth","volume":"94","author":"Maxwell","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.106.032920_REF25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4161\/cc.3.2.689","article-title":"HIF-1: a target for cancer, ischemia and inflammation-too good to be true?","volume":"3","author":"Melillo","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1124\/mol.106.032920_REF26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1593\/neo.05334","article-title":"A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells","volume":"7","author":"Merighi","year":"2005","journal-title":"Neoplasia"},{"key":"10.1124\/mol.106.032920_REF27","doi-asserted-by":"crossref","first-page":"19516","DOI":"10.1074\/jbc.M413772200","article-title":"A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase\/Akt-dependent inhibition of the extracellular signal-regulated kinase 1\/2 phosphorylation in A375 human melanoma cells","volume":"280","author":"Merighi","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.106.032920_REF28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bcp.2006.03.020","article-title":"Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells","volume":"72","author":"Merighi","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.106.032920_REF29","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.bjp.0704352","article-title":"Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line","volume":"134","author":"Merighi","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.106.032920_REF30","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnci\/dji039","article-title":"Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer","volume":"97","author":"Michels","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/mol.106.032920_REF31","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nm1294","article-title":"Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells","volume":"11","author":"Mizukami","year":"2005","journal-title":"Nat Med"},{"key":"10.1124\/mol.106.032920_REF32","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/S0002-9440(10)63749-2","article-title":"Adenosine A2A receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis","volume":"164","author":"Montesinos","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1124\/mol.106.032920_REF33","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/82113","article-title":"Targeting tumors through the HIF system","volume":"6","author":"Ratcliffe","year":"2000","journal-title":"Nat Med"},{"key":"10.1124\/mol.106.032920_REF34","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/mol.106.032920_REF35","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bcp.2005.08.018","article-title":"Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors","volume":"70","author":"Varani","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.106.032920_REF36","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0026-895X(24)26507-X","article-title":"[3H]MRE 3008F20: a novel antagonist radio-ligand for the pharmacological and biochemical characterization of human A3 adenosine receptors","volume":"57","author":"Varani","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.032920_REF37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/(SICI)1097-0215(19990611)81:6<845::AID-IJC1>3.0.CO;2-5","article-title":"Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumour progression","volume":"81","author":"Wong","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1124\/mol.106.032920_REF38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00008469-200204000-00005","article-title":"Coffee and tea consumption and cancers of the bladder, colon and rectum","volume":"11","author":"Woolcott","year":"2002","journal-title":"Eur J Cancer Prev"},{"key":"10.1124\/mol.106.032920_REF39","series-title":"Food, Nutrition and the Prevention of Cancer: A Global Perspective","first-page":"216","year":"1997"},{"key":"10.1124\/mol.106.032920_REF40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1359-6101(01)00016-8","article-title":"Interleukin-8 and human cancer biology","volume":"12","author":"Xie","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1124\/mol.106.032920_REF41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ddr.10212","article-title":"Expression and function of A2B adenosine receptors in the U87MG tumor cells","volume":"58","author":"Zeng","year":"2003","journal-title":"Drug Dev Res"},{"key":"10.1124\/mol.106.032920_REF42","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24045309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24045309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.106.032920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:54:05Z","timestamp":1739966045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24045309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0026895X24045309"],"URL":"https:\/\/doi.org\/10.1124\/mol.106.032920","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caffeine Inhibits Adenosine-Induced Accumulation of Hypoxia-Inducible Factor-1\u03b1, Vascular Endothelial Growth Factor, and Interleukin-8 Expression in Hypoxic Human Colon Cancer Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.106.032920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}